Cite
HARVARD Citation
Callewaert, T. et al. (n.d.). P115 Quality-of-life analysis in the randomized phase II CLIO trial comparing olaparib with standard chemotherapy in platinum-resistant recurrent ovarian cancer. International journal of gynecological cancer. pp. A129-A130. [Online].